{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.73 vs. cons $0.68",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$14.5B vs. cons $14.4B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Ex-COVID / Launched-&-acquired revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~+7% op ($3.2B basket) vs. cons ~+5%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.80-3.00 (mid $2.90) vs. cons $2.98 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Revenue guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$59.5-62.5B (mid $61.0B) vs. cons $61.2B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital allocation / buyback signal & dividend safety",
      "prediction": "UNKNOWN",
      "answer": "guide ~$0.43/qtr div maintained, buyback back in consideration vs. cons no repurchase assumption (2H26)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.0,
  "day5_path": "FADE",
  "day5_rationale": "A cost-driven EPS beat with only a reaffirmed (not raised) FY26 guide and COVID-seasonal, LOE-pressured revenue gives no upward out-period revision fuel; implicit second-half math and durable LOE/COVID-erosion concerns pull estimates back down, so an initial pop on the beat and ~7% yield support tends to fade toward flat over five days absent a pipeline/obesity catalyst.",
  "day5_confidence": "MEDIUM"
}